Mon, 10 Sep 2007 15:58:53 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY, 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/ophthalmology/podcast_Ophthalmology_album_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Ophtalmology no PeerView Press In this CME activity, an expert in the management of age-related macular degeneration discusses recent data on the incorporation of anti-VEGF agents—either alone or in combination—into treatment regimens. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, an expert in the management of age-related macular degeneration discusses recent data on the incorporation of anti-VEGF agents—either alone or in combination—into treatment regimens. http://podcast.peerviewpress.com/ophthalmology/PA03643FCp118.mp3 http://podcast.peerviewpress.com/ophthalmology/PA03643FCp118.mp3 Thu, 06 Sep 2007 15:49:18 -0400 Science no 00:32:04 age-related macular degeneration, ranibizumab, pegaptanib, bevacizumab, verteporfin, thermal laser photocoagulation, antioxidants, vitamins, photodynamic therapy, PDT, vascular endothelial growth factor, elderly, geriatrics, exudative AMD PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/ophthalmology/PA03643FCp118CMEinfo.pdf http://podcast.peerviewpress.com/ophthalmology/PA03643FCp118CMEinfo.pdf Thu, 06 Sep 2007 15:49:14 -0400 Science no 00:00:00 age-related macular degeneration, ranibizumab, pegaptanib, bevacizumab, verteporfin, thermal laser photocoagulation, antioxidants, vitamins, photodynamic therapy, PDT, vascular endothelial growth factor, elderly, geriatrics, exudative AMD PeerView Press In this CME activity, experts in the treatment of diabetes and diabetic retinopathy present recent data on the efficacy of emerging agents used in the treatment of diabetic macular edema. The molecular mechanisms for the development of this condition are reviewed. Recent updates in the management of diabetes are highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of diabetes and diabetic retinopathy present recent data on the efficacy of emerging agents used in the treatment of diabetic macular edema. The molecular mechanisms for the development of this condition are reviewed. Recent updates in the management of diabetes are highlighted. http://podcast.peerviewpress.com/ophthalmology/PA03009FCs387.mp3 http://podcast.peerviewpress.com/Ophthalmology/PA03009FCs387.mp3 Wed, 28 Feb 2007 15:54:38 -0500 Science no 00:35:36 diabetic retinopathy, diabetic macular edema, laser photocoagulation, ruboxistaurin, pegaptanib, ranibizumab, triamcinolone, fluocinolone, dexamethasone, macular edema, protein kinase C, vitrectomy, polyol pathway, steroids, advanced glycation endproducts PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/ophthalmology/PA03009FCCMEinfo.pdf http://podcast.peerviewpress.com/Ophthalmology/PA03009FCCMEinfo.pdf Wed, 28 Feb 2007 15:54:17 -0500 Science no 00:00:00 diabetic retinopathy, diabetic macular edema, laser photocoagulation, ruboxistaurin, pegaptanib, ranibizumab, triamcinolone, fluocinolone, dexamethasone, macular edema, protein kinase C, vitrectomy, polyol pathway, steroids, advanced glycation endproducts PeerView Press In this activity, experts in the treatment of age-related macular degeneration (AMD) present current data on the efficacy and safety of anti-VEGF agents used in the treatment of the wet form of this condition. Strategies for incorporating anti-VEGF agents into the management plan are also discussed. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of age-related macular degeneration (AMD) present current data on the efficacy and safety of anti-VEGF agents used in the treatment of the wet form of this condition. Strategies for incorporating anti-VEGF agents into the management plan are also discussed. http://podcast.peerviewpress.com/ophthalmology/PA03348FCinR206.mp3 http://podcast.peerviewpress.com/Ophthalmology/PA03348FCinR206.mp3 Wed, 17 Jan 2007 15:00:22 -0500 Science no 00:24:24 age-related macular degeneration, ranibizumab, pegaptanib, bevacizumab, verteporfin, vascular endothelial growth factor, elderly, geriatrics, exudative AMD, neovascularization, angiogenesis, VEGF, wet AMD, blindness, endophthalmitis PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/ophthalmology/PA03348FCCMEinfo.pdf http://podcast.peerviewpress.com/Ophthalmology/PA03348FCCMEinfo.pdf Wed, 17 Jan 2007 15:00:10 -0500 Science no 00:00:00 age-related macular degeneration, ranibizumab, pegaptanib, bevacizumab, verteporfin, vascular endothelial growth factor, elderly, geriatrics, exudative AMD, neovascularization, angiogenesis, VEGF, wet AMD, blindness, endophthalmitis PeerView Press In this activity, experts in the treatment of diabetes and diabetic retinopathy present current efficacy and safety data on emerging medications for the treatment of diabetic macular edema. A discussion about the multiple mechanisms thought to lead to the development of diabetic microvascular changes is featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of diabetes and diabetic retinopathy present current efficacy and safety data on emerging medications for the treatment of diabetic macular edema. A discussion about the multiple mechanisms thought to lead to the development of diabetic microvascular changes is featured. http://podcast.peerviewpress.com/ophthalmology/PA02163FCinR177.mp3 http://podcast.peerviewpress.com/Ophthalmology/PA02163FCinR177.mp3 Fri, 28 Jul 2006 10:02:38 -0400 Science no 00:18:27 diabetic retinopathy,diabetic macular edema,laser photocoagulation,ruboxistaurin,pegaptanib,ranibizumab,triamcinolone,fluocinolone,dexamethasone,macular edema,protein kinase C,vitrectomy,polyol pathway,steroids,advanced glycation endproducts,hexosamine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/ophthalmology/PA02163FCCMEinfo.pdf http://podcast.peerviewpress.com/Ophthalmology/PA02163FCCMEinfo.pdf Fri, 28 Jul 2006 10:02:14 -0400 Science no 00:00:00 diabetic retinopathy,diabetic macular edema,laser photocoagulation,ruboxistaurin,pegaptanib,ranibizumab,triamcinolone,fluocinolone,dexamethasone,macular edema,protein kinase C,vitrectomy,polyol pathway,steroids,advanced glycation endproducts,hexosamine PeerView Press In this activity, experts in the treatment of age-related macular degeneration discuss recent data on efficacy and safety of current and emerging vascular endothelial growth factor inhibitors used in the management of this condition. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of age-related macular degeneration discuss recent data on efficacy and safety of current and emerging vascular endothelial growth factor inhibitors used in the management of this condition. http://podcast.peerviewpress.com/Ophthalmology/PA02246FCophmay06a.mp3 http://podcast.peerviewpress.com/Ophthalmology/PA02246FCophmay06a.mp3 Tue, 27 Jun 2006 11:22:24 -0400 Science no 00:18:42 age-related macular degeneration,ranibizumab,pegaptanib,bevacizumab,verteporfin,thermal laser photocoagulation,antioxidants,vitamins,photodynamic therapy,vascular endothelial growth factor,elderly,geriatrics,exudative AMD,neovascularization,angiogenesis PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Ophthalmology/PA02246FCCMEinfo.pdf http://podcast.peerviewpress.com/Ophthalmology/PA02246FCCMEinfo.pdf Tue, 27 Jun 2006 11:22:17 -0400 Science no 00:00:00 age-related macular degeneration,ranibizumab,pegaptanib,bevacizumab,verteporfin,thermal laser photocoagulation,antioxidants,vitamins,photodynamic therapy,vascular endothelial growth factor,elderly,geriatrics,exudative AMD,neovascularization,angiogenesis